Recent Newsletters
R.J. Hedges & Associates

Our newsletters keep you informed about current healthcare issues and regulatory changes, events, and accreditation discrepancies.
See past newsletter editions below.

2022
November 2022

End of an era NSC ends contract, 2023 Medicare Deductibles, USP updates, and enforcements

October 2022

NSG Ends Contract November 6th, USP updates are finally coming to USP <795> and <800>, and TriCare Beneficiaries are being forced to move to Mandatory Mail order of Chain Pharmacies Only.

September 2022

Fall means Open Enrollment and Flu Vaccines, COVID, DMEPOS, and DSCSA Updates.

August 2022

HIPAA Regulations updates are coming, DME errors reporting is showing high documentation errors, and the NCPA is asking members to send letters to the FDA to stop restrictions on compounded hormone therapy.

July 2022

Supreme Court ruling could impact DEA investigations on pharmacies for Opioid dispensing, Multi-state, Multi-agency strike force to target illegal prescribing of controlled drugs in New England, Pa’s PALS Licensing system no longer issuing new licenses for O&P, Clarification on USP <800>.

June 2022

HIPAA Communications Requirement Update, Attn PIC’s- listen Medicare Part D Final Rule, CGM’s now permitted with TriCare

May 2022

DIR fees to change in 2023, COVID-19 Fraud cases start, FDA limits use on J&J’s COVID Vaccine, HIPAA and DEA Enforcement Actions, COVID’s winding down- time to prepare for life prior to waivers

April 2022

They’re back! Time to prepare for Audits and Inspections to start again, Prior Authorizations for certain Orthoses are being suspended, and Free COVID tests to Medicare Beneficiaries

March 2022

NSC Site inspections new contractors off to rocky start, COVID Standing Orders Updated, Time to review your Medication Adherence Program, notice of expected changes to Compliance Programs, CBD Book coming to market available from R.J. Hedges & Associates

February 2022

Surgical Dressings update with Medicare Requirements and Updates to Policies & Forms

January 2022

OSHA mandate on COVID Vaccines for employers with 100+ employees struck down, Pharmacists role post COVID research shows pharmacists have a greater role providing their care.